Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

by admin June 11, 2025
June 11, 2025
RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Download the PDF here.

This post appeared first on investingnews.com

previous post
Rapid Increases Land Holding by 26 X
next post
Hyundai Builds Rare Earths Stockpile to Offset Supply Risks

Related Posts

Prospectus

June 20, 2025

Empire Metals: Advancing a Game-changing, Globally Significant Titanium...

May 1, 2025

$4,000 Gold on the Horizon? Why Smart Money...

April 26, 2025

Cygnus raises $18.3m to accelerate resource growth and...

June 20, 2025

StrategX Discovers High-Grade Copper at East Arm, Great...

February 20, 2025

Crypto Market Recap: Grayscale Debuts Bitcoin ETFs, SEC...

April 4, 2025

Altech Batteries LtdCERENERGY Cells Test Safe Under Extreme...

April 3, 2025

Crypto Market Recap: Bitcoin Holds Above US$90,000, Strategy...

April 29, 2025

Edjudina Gold Project, WA – Permitting Application to...

March 26, 2025

LME Copper vs. COMEX Copper

January 31, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved